Press Resease

HbA1c Testing Device Market - Global Industry Analysis

HbA1c Testing Device Market By Product (Handheld Device and Bench-top Device), By Technology (Ion-exchange HPLC, and Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay and Other), By Application (Hospital, Homecare, and Diagnostic laboratory): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 26-Jul-2021 Category: Medical Device Report Format : PDF Pages: 145 Report Code: ZMR-352 Status : Published

The global HbA1c Testing Device market accounted for USD 1.7 Billion in 2020 and is expected to reach USD 4.1 Billion by 2028, growing at a CAGR of 11.5% from 2021 to 2028.

Description

Market Overview                                                  

The global HbA1c Testing Device market accounted for USD 1.7 Billion in 2020 and is expected to reach USD 4.1 Billion by 2028, growing at a CAGR of 11.5% from 2021 to 2028.     

HbA1c also called as Hemoglobin A1c. It is the blood test performed for diagnosis and monitoring Product of diabetes. Hemoglobin is a protein that links with sugars such as glucose found inside red blood cells. High amount of glucose increases the risk of diabetes. This test reports the amount of HbA1c as a proportion of total hemoglobin in the blood stream.

The giant players in the market are focusing on launching new products to expand their product portfolio and customer base. For instance, in June 2019, Transasia Biomedicals ltdott Laboratories launched Afinion HbA1c Dx test, a 3-minute, in-office A1c blood test for diagnosing diabetes. Moreover, Reportedly, on 20th August 2018, National Institutes of Health conducted the study and revealed that blood test carried out during the tenth week of pregnancy can assist in identifying the risks related to gestational diabetes occurrence. 

COVID-19 Impact Analysis:

Due to government-imposed lockdowns to prevent the spreading of COVID, the global HbA1c Testing Device industry has seen a small decline in revenues in the short. As healthcare professionals increasingly direct their resources towards caring for coronavirus-infected patients, other health issues are being relegated to the back seat. The players in the industry have temporarily suspended the production of HbA1c Testing Device in order to cater corona virus patients.

The significant decrease in the global HbA1c Testing Device market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.  

Growth Factors  

Steep rise in population of diabetics along with prominent cases of diabetes witnessed across the countries having low-income & middle-income population is predicted to propel the demand for Hba1c testing. Apart from this, increase in the awareness levels pertaining to preventive care and diabetes management will further drive the growth of Hba1c testing device market in the years ahead.  Introduction of new technologies for measuring HbA1c will further contribute towards the HbA1C testing device market revenue over the ensuing years.

Escalating product costs and lack of accuracy in the derived outcomes observed from clinical tests performed on pregnant women, old persons, and non-Hispanic black population, is anticipated to obstruct the Hba1c testing device market progression in the near future. Nevertheless, unexplored market potential and global popularity of medical tourism is projected to provide lucrative opportunities for the industry growth in the coming years, thereby normalizing the impact of hindrances on the Hba1c testing device market.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Product Segment Analysis Preview

On the basis of Product, the global gas market is segmented into Handheld Device and Bench-top Device. Bench-top Device segment held the largest market share due to bench-top HbA1c testing device is relatively higher and the trend is anticipated to remain so over the next few years.

Technology Segment Analysis Preview  

On the basis of Technology, HbA1c Testing Device market is segmented into Ion-exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay and Other. Ion-exchange HPLC technology is the most widely used for hemoglobin A1c testing and gives accurate HbA1c values in the presence of hemoglobin variants in the case of a highly diversified population.

 Application Segment Analysis Preview

On the basis of Application, HbA1c Testing Device market is segmented into Hospital, Homecares, and Diagnostic laboratory. Hospital segment held the largest market share due to huge demand across the globe for the growth of HbA1c Testing Device market.

Regional Segment Analysis Preview

North America has been leading the worldwide Hba1c testing device market and is anticipated to continue on the dominant position in the years to come, states the Hba1c testing device market study. The presence of a well-established healthcare infrastructure and growing incidences of diabetes mellitus witnessed in the region is the main factor behind the dominance of the North America Hba1c testing device market.

Key Market Players & Competitive Landscape

The major players operating in the HbA1c Testing Device market are Transasia Biomedicals ltd., Transasia Biomedicals ltdott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc.

The global HbA1c Testing Device market is segmented as follows:   

By Product

  • Handheld Device
  • Bench-top Device

By Technology  

  • Ion-exchange HPLC
  • Enzymatic assay
  • Affinity binding chromatography
  • Turbidimetric inhibition immunoassay
  • Other

By Application

  • Hospital
  • Homecare
  • Diagnostic laboratory

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By Technology
        • 2.1.1.3. Market Attractiveness Analysis, By Application
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global HbA1c Testing Device Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 HbA1c Testing Device Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Handheld Device
      • 4.2.1. Market Application and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Bench-top Device
      • 4.3.1. Market Application and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 HbA1c Testing Device Market – Technology Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Technology, 2020 & 2028
    • 5.2. Ion-exchange HPLC
      • 5.2.1. Market Application and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Enzymatic assay
      • 5.3.1. Market Application and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Affinity binding chromatography
      • 5.4.1. Market Application and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Turbidimetric inhibition immunoassay
      • 5.5.1. Market Application and Forecast, By Region (USD Billion)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Others
      • 5.6.1. Market Application and Forecast, By Region (USD Billion)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 HbA1c Testing Device Market – Application Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 6.2. Hospital
      • 6.2.1. Market Application and Forecast, By Region (USD Billion)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Homecare
      • 6.3.1. Market Application and Forecast, By Region (USD Billion)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Diagnostic laboratory
      • 6.4.1. Market Application and Forecast, By Region (USD Billion)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 HbA1c Testing Device Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Technology, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Application, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Technology, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Application, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Technology, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Application, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Technology, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Application, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Technology, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Application, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Technology, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Application, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Product, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Technology, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Application, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Technology, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Application, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Technology, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Application, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Technology, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Application, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Technology, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Technology, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Product, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Technology, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Application, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Technology, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Application, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Product, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Technology, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Application, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Technology, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Application, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Technology, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Technology, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Technology, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Application, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Technology, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Application, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Technology, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Application, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Technology, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Technology, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Technology, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Technology, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Technology, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 8 HbA1c Testing Device Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Product Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global HbA1c Testing Device Market: Company Market Share, 2019
      • 9.1.2. Global HbA1c Testing Device Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 9.1.3. Global HbA1c Testing Device Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global HbA1c Testing Device Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. TRANSASIA BIOMEDICALS LTD
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. Abbott Laboratories
    • 10.3. Alere, Inc
    • 10.4. Arkray, Inc
    • 10.5. Bio-Rad Laboratories, Inc
    • 10.6. Danaher Corporation
    • 10.7. F. Hoffmann-La Roche Ltd
    • 10.8. Siemens Healthcare
    • 10.9. Trinity Biotech plc
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Technology Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Hba1c Testing Device Market market. Zion Research has collected and analyzed key data belong to the global Hba1c Testing Device Market market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Hba1c Testing Device Market across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Hba1c Testing Device Market industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Hba1c Testing Device Market market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Hemoglobin is the iron containing and oxygen transporting metalloprotein found in the red blood cells of vertebrates. HbA1c is a form of hemoglobin to which glucose binds in the red blood cells and it is also referred as glycated hemoglobin. Diabetes mellitus is a metabolic disorder characterized by disturbances of carbohydrate and chronic hyperglycemia resulting from defects in insulin secretion. The long–term effects of diabetes mellitus include the development of nephropathy, neuropathy, and retinopathy. People with diabetes mellitus are also at a risk of cerebrovascular disease, peripheral arterial, and cardiac diseases. HbA1c is an ideal marker for diabetes monitoring and diagnosis. HbA1c molecule reflects average glucose level over the previous eight to 12 weeks.

The increasing prevalence of raised blood sugar or hyperglycemia is a common effect of uncontrolled diabetes mellitus and it has affected around 422 million people in 2014. This global prevalence of diabetes has increased by 8.5% in 2014. Thus, the market for HbA1c testing device is propelled by rising diabetic adult population and rising prevalence of diabetes in middle and low-income countries. Moreover, HbA1c testing device market is rapidly growing due to rising awareness preventive care and diabetes management. Diabetes has emerged as one of the most challenging public health problems and it is a major cause of stroke, blindness, heart attacks and kidney failure. Thus, diabetic patient education becomes a prime component of diabetes management. In addition, technological advancement in HbA1c measurement is continuously responsible for the growth of HbA1c testing device market. Recently, HbA1c testing has been incorporated into point of care devices. However, the cost of the device and low diagnostic performance of test in pregnancy, elderly and non-Hispanic black population may hamper the growth of HbA1c testing device market. Nonetheless, untapped market and rapidly rising use of the HbA1c test for diabetes management are projected to generate opportunity in the forecast period.

Global HbA1c Testing Device market

Based on the device type, the market of the HbA1c testing device has been bifurcated into the handheld device and bench-top device. In 2015, bench-top device segment dominated the market for HbA1c testing device with major market share. In the forecast period, handheld device segment is expected to exhibit noticeable growth due to rising awareness of personal care.

Technology type segment has been further classified into ion-exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay and other. In 2015, affinity binding chromatography segment dominated the HbA1c testing device market and the dominance of affinity binding chromatography is due to widely use of technology in device manufacturing. As a result of this, it is expected to generate new opportunities in the forecast period. Affinity binding chromatography technology uses the principle of affinity and high-performance liquid chromatography (HPLC). Affinity binding chromatography requires no sample pretreatment to remove the labile.

Based on the end user type, the HbA1c testing device market is classified into hospitals, homecare, research institutions and diagnostic laboratory. The diagnostic laboratory was the largest segment in 2015 and it is expected to show significant growth in the forecast period.

Based on the regional, the HbA1c testing device market is classified into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America dominated the HbA1c testing device market in 2015 with around 40% market share. North America HbA1c testing device market was driven by well-developed healthcare infrastructure and rising prevalence of diabetes mellitus. Europe and Asia Pacific market are projected to show healthy growth in coming years.

Key operating players in HbA1c testing device market include Transasia Biomedicals Ltd., Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc.


Frequently Asked Questions

The global HbA1c Testing Device market was valued at USD 1.7 Billion in 2020.

The global HbA1c Testing Device market is expected to reach USD 4.1 Billion by 2028, growing at a CAGR of 11.5% between 2021 to 2028.

Major driving factors for the growth of HbA1c Testing Device market are increasing demand for Steep rise in population of diabetics along with prominent cases of diabetes witnessed across the countries having low-income & middle-income population.  

North America has been leading the worldwide Hba1c testing device market and is anticipated to continue on the dominant position in the years to come, states the Hba1c testing device market study. The presence of a well-established healthcare infrastructure and growing incidences of diabetes mellitus witnessed in the region is the main factor behind the dominance of the North America Hba1c testing device market.

The major players operating in the HbA1c Testing Device market are Transasia Biomedicals ltd., Transasia Biomedicals ltdott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social